High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma

Annals of Oncology

Volumn 8, Issue 3, 1997, Pages 243-246

  Goldschmidt, H ^a   Hegenbart, U ^a   Wallmeier, M ^a   Hohaus, S ^a   Engenhart, R ^a   Wannenmacher, M ^a   Haas, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

high dose melphalan; multiple myeloma; peripheral blood progenitor cell transplantation; total body irradiation

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; VINCRISTINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0030905105     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008252227512     Document Type: Article

References (14)

1. Alexanian R, Dimopoulos M. The treatment of multiple myeloma. N Engl J Med 1994; 330: 484-9.
2. Samson D. Principles of chemotherapy and radiotherapy. In Gahrton M. Durie BGM (eds): Multiple Myeloma. London, Sydney, Auckland: Arnold 1996; 108-29.
3. Gregory WM, Richards MA, Malpas JS. Combination therapy versus melphalan and prednisolone in the treatment of multiple myeloma: An overview of published trials. J Clin Oncol 1992; 10: 334-42.
4. McElwain TJ, Powles RL. High-dose intravenous melphalan for plasma cell leukemia and myeloma. Lancet 1983; 2: 822-4.
5. Attal M, Harousseau JL, Stoppa et al. High dose therapy in multiple myeloma: Final analysis of a prospective randomized study of the 'Intergroup Francais Du Myelome' (1FM 90). N Engl J Med 1996; 335: 91-7.
6. Durie B, Salmon S. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-52.
7. Attal M. A randomized study testing the effect of bone marrow/ peripheral blood stem cell transplantation or conventional chemotherapy, with or without alpha interferon for aggressive myeloma. EORTC Leukemia Cooperative Group, EBMT Myeloma Study Group, French Myeloma Study Groups (GEM-POF) 1993.
8. Murea S, Goldschmidt H, Hahn U et al. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukapheresis. J Clin Apher 1996; 11: 185-94.
9. Hohaus S, Goldschmidt H, Ehrhardt R et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-14.
10. Barlogie B, Crowley J, Jagannath S et al. Superior outcome after early autotransplantation (AT) with 'Total Therapy' (TT) compared to standard SWOG treatment (ST) for multiple myeloma (MM). Blood 1995; 86: 207a (Abstr).
11. Cunningham D, Paz-Ares L, Milan S et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 1994; 12: 759-63.
12. Jagannath S, Barlogie B. Autologous bone marrow transplantation for multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 451-62.
13. Vesole DH, Barlogie B, Jagannath S et al. High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950-6.
14. Mohrbacher A, Anderson KC: Bone marrow transplantation in multiple myeloma. In Malpas JS, Bergsagel DE, Kyle RA (eds): Myeloma. Biology and Management. Oxford: Oxford University Press 1995: 322-52.